Evidence map›Paper›PMID 22814351›Full record

ReviewNature immunology2012

IL-12 family cytokines: immunological playmakers.

Dario A A Vignali, Vijay K Kuchroo

Registry-linked trialAbstract readReview
In one paragraph

Review in Nature immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05281848 (Evaluation of the Effect of Non-surgical Periodontal Treatment on Salivary and Gingival Crevicular Fluid Levels of IL-17 and IL-35 in Periodontitis Patients as Smoker and Non-smoker), which is not on this map. Cited by 669 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
669citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05281848 nacompletednot on this mapstarted 2018, after this paper: background citation

Evaluation of the Effect of Non-surgical Periodontal Treatment on Salivary and Gingival Crevicular Fluid Levels of IL-17 and IL-35 in Periodontitis Patients as Smoker and Non-smoker

TypeinterventionalSponsorGazi UniversityRan2018 to 2022Enrolled55ConditionsPeriodontitis, Periodontal Diseases, Smoking, Smoking, TobaccoArmsNon-surgical periodontal treatment
3 · Its place in the literature

Who cites it

669 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Sex Steroid Hormone Regulation of T-Cell Function and Antitumor Immunity.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Review
  9. Review
  10. Article
  11. Designing lysate-based hydrogels for on-demand therapy.Journal of pharmaceutical analysis · 2026
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Type I interferon-induced CD169Journal of periodontology · 2026
    Article
  20. Review

609 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dario A A VignaliDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. vignali.lab@stjude.org
Vijay K Kuchroo

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
T CELL RESPONSE TO MYELIN PROTEOLIPID PROTEINR01NS030843 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI KUCHROO, VIJAY K. · 1998 to 2019
$4.1M
T cell response to myelin proteolipid proteinR37NS030843 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI KUCHROO, VIJAY K. · 2002 to 2008
$2.6M
A Regulatory Triad: IL35, Tregs and iTr35R01AI091977 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VIGNALI, DARIO AA · 2011 to 2015
$2.0M
Interleukin-35 and the tumor microenvironmentR01CA203689 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VIGNALI, DARIO AA · 2016 to 2020
$1.9M
TCELL RESPONSE TO MYELIN PROTEOLIPID PROTEINR29NS030843 · NINDS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KUCHROO, VIJAY K · 1992 to 1996
–
NCI NIH HHS CA21765NCI NIH HHS P30 CA021765NCI NIH HHS R01 CA203689NIAID NIH HHS AI091977NIAID NIH HHS R01 AI091977NINDS NIH HHS NS30843NINDS NIH HHS R01 NS030843NINDS NIH HHS R29 NS030843NINDS NIH HHS R37 NS030843
6 · The paper itself

Abstract

The interleukin 12 (IL-12) family is unique in having the only heterodimeric cytokines, including IL-12, IL-23, IL-27 and IL-35. This feature endows these cytokines with a unique set of connections and functional interactions not shared by other cytokine families. Despite sharing many structural features and molecular partners, cytokines of the IL-12 family mediate surprisingly diverse functional effects. Here we discuss the unique and unusual structural and functional characteristics of this cytokine family. We outline how cells might interpret seemingly similar cytokine signals to give rise to the diverse functional outcomes that characterize this cytokine family. We also discuss the therapeutic implications of this complexity.

Indexed as

Signal TransductionHumansInflammationInflammation MediatorsInterleukin-12Interleukin-17Interleukin-23InterleukinsProtein MultimerizationT-LymphocytesInflammation MediatorsInterleukin-12Interleukin-17Interleukin-23interleukin-35, humanInterleukins

Identifiers

PMID22814351
PMCPMC4158817

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.